Previous Close | 136.94 |
Open | 137.22 |
Bid | 135.56 x 900 |
Ask | 136.76 x 1100 |
Day's Range | 136.11 - 137.62 |
52 Week Range | 119.59 - 145.58 |
Volume | |
Avg. Volume | 989,818 |
Market Cap | 15.124B |
Beta (5Y Monthly) | 0.89 |
PE Ratio (TTM) | 18.30 |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | 3.00 (2.19%) |
Ex-Dividend Date | Apr 05, 2024 |
1y Target Est | N/A |
Quest Diagnostics' (DGX) pathology laboratories nationwide are set to get a boost with PathAI's AISight digital pathology image management system.
Investors are optimistic about Quest Diagnostics (DGX) on strong legacy business growth.
Quest Diagnostics' (DGX) latest transaction combines its oncology expertise and scale with PathAI's AI and digital pathology innovations.